Daré Bioscience, Inc. (DARE)
0.7344
+0.03
(+4.02%)
USD |
NASDAQ |
Sep 14, 16:00
0.7344
0.00 (0.00%)
After-Hours: 17:31
Daré Bioscience Market Cap : 11.14M for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 10.71M |
| September 10, 2026 | 10.70M |
| September 09, 2026 | 10.87M |
| September 08, 2026 | 10.82M |
| September 04, 2026 | 10.94M |
| September 03, 2026 | 10.82M |
| September 02, 2026 | 11.23M |
| September 01, 2026 | 11.68M |
| August 31, 2026 | 11.54M |
| August 28, 2026 | 11.15M |
| August 27, 2026 | 11.21M |
| August 26, 2026 | 11.39M |
| August 25, 2026 | 12.45M |
| August 24, 2026 | 12.16M |
| August 21, 2026 | 12.44M |
| August 20, 2026 | 12.28M |
| August 19, 2026 | 12.51M |
| August 18, 2026 | 11.65M |
| August 17, 2026 | 12.29M |
| August 14, 2026 | 14.11M |
| August 13, 2026 | 20.78M |
| August 12, 2026 | 21.84M |
| August 11, 2026 | 21.84M |
| August 10, 2026 | 19.80M |
| August 07, 2026 | 20.38M |
| Date | Value |
|---|---|
| August 06, 2026 | 19.36M |
| August 05, 2026 | 19.51M |
| August 04, 2026 | 19.51M |
| August 03, 2026 | 18.64M |
| July 31, 2026 | 17.76M |
| July 30, 2026 | 18.05M |
| July 29, 2026 | 16.89M |
| July 28, 2026 | 17.25M |
| July 27, 2026 | 19.22M |
| July 24, 2026 | 18.64M |
| July 23, 2026 | 18.34M |
| July 22, 2026 | 17.76M |
| July 21, 2026 | 18.20M |
| July 20, 2026 | 19.51M |
| July 17, 2026 | 28.54M |
| July 16, 2026 | 28.25M |
| July 15, 2026 | 30.14M |
| July 14, 2026 | 30.14M |
| July 13, 2026 | 30.43M |
| July 10, 2026 | 29.41M |
| July 09, 2026 | 30.14M |
| July 08, 2026 | 29.56M |
| July 07, 2026 | 29.85M |
| July 06, 2026 | 30.28M |
| July 02, 2026 | 30.43M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 2.335B |
| Elite Pharmaceuticals, Inc. | 283.29M |
| Eton Pharmaceuticals, Inc. | 1.628B |
| ANI Pharmaceuticals, Inc. | 1.616B |
| Corcept Therapeutics, Inc. | 12.05B |
Market Cap Related Metrics
| PS Ratio | 7.617 |
| Price | 0.7344 |
| Earnings Yield | -107.0% |